NCT04325217View on ClinicalTrials.gov

Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan

Active, not recruitingOBSERVATIONAL
Enrollment

586

Participants

Timeline

Start Date

May 27, 2020

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2026

Conditions
Lung Diseases, Interstitial
Interventions
DRUG

Nintedanib

Capsules

Trial Locations (1)

1416017

Nippon Boehringer Ingelheim Co., Ltd., Tokyo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY